Brokerages Anticipate Stryker Corporation (SYK) to Announce $1.95 Earnings Per Share

Equities research analysts expect Stryker Corporation (NYSE:SYK) to report $1.95 earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Four analysts have made estimates for Stryker’s earnings, with estimates ranging from $1.93 to $1.97. Stryker posted earnings of $1.78 per share in the same quarter last year, which would suggest a positive year over year growth rate of 9.6%. The firm is expected to announce its next earnings report after the market closes on Tuesday, January 30th.

According to Zacks, analysts expect that Stryker will report full year earnings of $6.48 per share for the current fiscal year, with EPS estimates ranging from $6.45 to $6.50. For the next financial year, analysts anticipate that the firm will report earnings of $7.12 per share, with EPS estimates ranging from $7.04 to $7.18. Zacks’ earnings per share averages are an average based on a survey of sell-side research firms that cover Stryker.

Stryker (NYSE:SYK) last posted its quarterly earnings data on Thursday, October 26th. The medical technology company reported $1.52 EPS for the quarter, beating analysts’ consensus estimates of $1.50 by $0.02. The company had revenue of $3.01 billion during the quarter, compared to analysts’ expectations of $2.97 billion. Stryker had a return on equity of 24.11% and a net margin of 14.67%. Stryker’s revenue for the quarter was up 6.1% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.39 earnings per share.

SYK has been the subject of a number of analyst reports. Wells Fargo & Co upped their price target on Stryker from $160.00 to $166.00 in a research report on Friday, October 27th. Canaccord Genuity upped their price target on Stryker from $155.00 to $162.00 and gave the stock a “buy” rating in a research report on Friday, October 27th. Stifel Nicolaus upped their price target on Stryker from $158.00 to $168.00 and gave the stock a “buy” rating in a research report on Friday, October 27th. Cowen set a $160.00 price target on Stryker and gave the stock a “buy” rating in a research report on Friday, October 6th. Finally, Royal Bank of Canada restated a “buy” rating and issued a $155.00 price target on shares of Stryker in a research report on Monday, October 2nd. Two analysts have rated the stock with a sell rating, nine have assigned a hold rating and thirteen have assigned a buy rating to the company’s stock. Stryker currently has a consensus rating of “Hold” and a consensus price target of $156.60.

Shares of Stryker (NYSE:SYK) traded up $1.24 on Wednesday, reaching $159.47. The company’s stock had a trading volume of 1,369,500 shares, compared to its average volume of 1,223,500. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.61 and a current ratio of 2.37. The stock has a market capitalization of $59,800.00, a PE ratio of 34.00, a price-to-earnings-growth ratio of 2.27 and a beta of 0.78. Stryker has a fifty-two week low of $119.17 and a fifty-two week high of $164.20.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 31st. Investors of record on Friday, December 29th will be paid a dividend of $0.47 per share. The ex-dividend date is Thursday, December 28th. This is a positive change from Stryker’s previous quarterly dividend of $0.43. This represents a $1.88 dividend on an annualized basis and a yield of 1.18%. Stryker’s dividend payout ratio is presently 40.09%.

In related news, insider Lonny J. Carpenter sold 5,000 shares of the stock in a transaction that occurred on Friday, November 3rd. The stock was sold at an average price of $155.34, for a total transaction of $776,700.00. Following the completion of the transaction, the insider now directly owns 83,207 shares of the company’s stock, valued at $12,925,375.38. The sale was disclosed in a filing with the SEC, which is available through this link. 7.40% of the stock is currently owned by corporate insiders.

A number of institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. boosted its stake in Stryker by 2.8% during the second quarter. Vanguard Group Inc. now owns 24,078,709 shares of the medical technology company’s stock valued at $3,341,643,000 after buying an additional 657,656 shares during the last quarter. BlackRock Inc. lifted its stake in shares of Stryker by 5.2% in the 2nd quarter. BlackRock Inc. now owns 23,115,853 shares of the medical technology company’s stock valued at $3,208,017,000 after purchasing an additional 1,139,082 shares during the last quarter. Jensen Investment Management Inc. lifted its stake in shares of Stryker by 11.3% in the 3rd quarter. Jensen Investment Management Inc. now owns 2,472,476 shares of the medical technology company’s stock valued at $351,141,000 after purchasing an additional 251,685 shares during the last quarter. Legal & General Group Plc lifted its stake in shares of Stryker by 2.8% in the 3rd quarter. Legal & General Group Plc now owns 1,805,572 shares of the medical technology company’s stock valued at $256,393,000 after purchasing an additional 49,143 shares during the last quarter. Finally, Wells Fargo & Company MN lifted its stake in shares of Stryker by 4.8% in the 3rd quarter. Wells Fargo & Company MN now owns 1,742,959 shares of the medical technology company’s stock valued at $247,536,000 after purchasing an additional 79,551 shares during the last quarter. 74.88% of the stock is owned by institutional investors.

COPYRIGHT VIOLATION NOTICE: “Brokerages Anticipate Stryker Corporation (SYK) to Announce $1.95 Earnings Per Share” was originally published by American Banking News and is owned by of American Banking News. If you are reading this article on another site, it was copied illegally and republished in violation of US and international copyright & trademark laws. The correct version of this article can be read at https://www.americanbankingnews.com/2018/01/17/brokerages-anticipate-stryker-corporation-syk-to-announce-1-95-earnings-per-share.html.

About Stryker

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Get a free copy of the Zacks research report on Stryker (SYK)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Stryker (NYSE:SYK)

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply